Hetta, H.F.; Alqifari, S.F.; Alshehri, K.; Alhowiti, A.; Alharbi, S.S.; Mirghani, H.; Alrasheed, T.; Mostafa, M.E.A.; Sheikh, M.; Elodemi, M.;
et al. Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 652.
https://doi.org/10.3390/ph18050652
AMA Style
Hetta HF, Alqifari SF, Alshehri K, Alhowiti A, Alharbi SS, Mirghani H, Alrasheed T, Mostafa MEA, Sheikh M, Elodemi M,
et al. Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2025; 18(5):652.
https://doi.org/10.3390/ph18050652
Chicago/Turabian Style
Hetta, Helal F., Saleh F. Alqifari, Khaled Alshehri, Amirah Alhowiti, Saud S. Alharbi, Hyder Mirghani, Tariq Alrasheed, Mohamed E. A. Mostafa, Mohammed Sheikh, Mahmoud Elodemi,
and et al. 2025. "Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis" Pharmaceuticals 18, no. 5: 652.
https://doi.org/10.3390/ph18050652
APA Style
Hetta, H. F., Alqifari, S. F., Alshehri, K., Alhowiti, A., Alharbi, S. S., Mirghani, H., Alrasheed, T., Mostafa, M. E. A., Sheikh, M., Elodemi, M., Alhumaid, S. A., Ramadan, Y. N., Abd Ellah, N. H., & Sayad, R.
(2025). Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis. Pharmaceuticals, 18(5), 652.
https://doi.org/10.3390/ph18050652
